FDA Warning Wire: Zika, Tattoos, Syringes, Supplements

By Jeff Overley (December 19, 2017, 7:03 PM EST) -- The U.S. Food and Drug Administration this week targeted unapproved sales of Zika virus tests and a tattoo pain reliever, denounced questionable sterilization of syringes, and directed extensive criticism toward a supplement maker's marketing and manufacturing practices.

Here's a look at the FDA's latest warning letters.

Unapproved Zika Tests Draw Fire

A letter to Florida-based Health-Chem Diagnostics LLC focused on the production of diagnostic tests for the Zika virus, which was declared a global emergency in 2016 after spreading rapidly through Latin America and raising the risk of birth defects.

According to the letter, an inspection of Health-Chem this year found...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!